您的位置:中国博士人才网 > 博士后招收 > 海外博士后招收 > 英国医学研究理事会毒理学中心招收博士后

关注微信

英国医学研究理事会毒理学中心招收博士后

时间:2013-08-13来源:博士人才网 作者:91boshi

‘Predicting Sensitivity to PI3K/mTOR Inhibition in Malignant Mesothelioma’

The Medical Research Council Toxicology Unit is an internationally renowned institution delivering field-changing mechanistic insights into toxicology and disease.

We are looking to appoint a Postdoctoral Scientist to join the Molecular Mechanisms of Cell Death group led by Prof. Marion MacFarlane to work in collaboration with Prof. Dean A Fennell (University of Leicester & Leicester University Hospitals) on a project funded by the British Lung Foundation on Asbestos-related Disease. You will carry out innovative research exploring the molecular mechanisms that regulate sensitivity to PI3K/mTOR inhibition in Malignant Mesothelioma. It is expected that this will lead to publications in high impact journals.

You should have a PhD in biochemistry, molecular biology or a related discipline with significant experience of PI3K/mTOR signalling and apoptosis in the context of cancer and have published articles in international peer-reviewed journals.

This is a three year fixed-term position with a starting salary in the range £28,083 – £28,984 per annum.

Interviews will be held on 12 September 2013.

For further information about the Toxicology Unit, please visit: http://www.mrctox.le.ac.uk/

Closing date for applications: 4 September 2013

Applications are handled by UK Shared Business Services; to apply please visit our job board at www.topcareer.jobs , please upload a CV & cover letter (saving the documents with reference IRC106715 included in the filename). Applicants who would like to receive this advert in an alternative format (e.g. large print, Braille, audio or hard copy), or who are unable to apply online should contact us by telephone on 01793 867000. Please quote the reference number.

为防止简历投递丢失请抄送一份至:boshijob@126.com(邮件标题格式:应聘职位名称+姓名+学历+专业+中国博士人才网)

中国-博士人才网发布

声明提示:凡本网注明“来源:XXX”的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。